This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
FTV vs. A: Which Stock Is the Better Value Option?
by Zacks Equity Research
FTV vs. A: Which Stock Is the Better Value Option?
Fortive (FTV) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Fortive (FTV) delivered earnings and revenue surprises of 5.38% and 0.99%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Agilent Technologies (A) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Agilent Technologies (A) closed at $130.99, marking a +0.85% move from the previous day.
The Zacks Analyst Blog Highlights Oracle, Progressive, MercadoLibre, Moderna and Agilent
by Zacks Equity Research
Oracle, Progressive, MercadoLibre, Moderna and Agilent are included in this Analyst Blog.
Top Stock Reports for Oracle, Progressive & MercadoLibre
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), The Progressive Corporation (PGR) and MercadoLibre, Inc. (MELI).
Agilent (A) Boosts DGG Segment With ProteoAnalyzer System
by Zacks Equity Research
Agilent (A) bolsters protein analysis capabilities with the ProteoAnalyzer system.
FTV vs. A: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FTV vs. A: Which Stock Is the Better Value Option?
Why Is Agilent (A) Up 12.8% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent (A) Enhances BioTek Cytation C10 With New Technology
by Zacks Equity Research
Agilent (A) adds a water immersion and confocal spinning disk technology to BioTek Cytation C10, enhancing image quality and reducing harmful effects on live-cell samples.
The Zacks Analyst Blog Highlights Visa, Marriott International, Parker-Hannifin, FedEx and Agilent Technologies
by Zacks Equity Research
Visa, Marriott International, Parker-Hannifin, FedEx and Agilent Technologies are part of the Zacks top Analyst Blog.